PHARMA
ASLAN Pharma Raises US$23 Million In Pre-IPO Financing Round
The financing round has attracted support from both new and existing investors, including from Taiwan.
Takeda, Altos Therapeutics To Develop Gastroparesis Treatment
The partnership will develop Altos’s proprietary compound ATC-1906 to address the symptoms of nausea and vomiting in gastroparesis patients.
Pfizer Builds Global Biotechnology Center In China
The Center will produce high-quality, affordable biosimilar medicines for patients in China and around the world.
Particle Measuring Systems Sets The Standard For Contamination Monitoring
Particle Measuring Systems has been the industry leader in contamination monitoring solutions since 1972, with a strong presence spanning the globe.
Astellas, UTokyo To Collaborate On Cholera Vaccine
The partnership will develop a rice-based oral vaccine against cholera and E. coli-related diarrheal diseases.
ASLAN’s Varlitinib Receives Orphan Drug Designation For Gastric Cancer
Varlitinib previously received orphan drug designation for cholangiocarcinoma in August 2015.
Sorrento, 3SBio Enter Immunotherapy Joint Venture In China
The joint venture agreement will develop and commercialize proprietary immunotherapies using chimeric antigen receptor T-cell technology.
Ultragenyx, Takeda To Develop Drugs For Rare Genetic Diseases
Ultragenyx and Takeda will work together to develop and commercialize therapies for rare genetic diseases.
Data Mining Reveals Unusual Use For Vitamin D
Vitamin D taken together with quetiapine reduces the risk of new-onset diabetes, a side effect of the latter drug.
